跳至主要内容
临床试验/NCT01304290
NCT01304290Unknown不适用

Glucose/Insulin Clamp on Solid Organ Transplant (Liver, Kidney, Pancreas and Heart) on Cadaveric Donors

McGill University Health Centre/Research Institute of the McGill University Health Centre2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
2
主要终点
• Drop in the inflammatory cytokine response after brain death after a minimum of 6 hours therapy with the GICT prior to organ procurement.

研究概览

简要总结

Our objective in this study will be to determine if implementing the glucose/insulin clamp (GICT) on cadaveric organ donors can:

  • Prevent hyperglycaemia

  • Drop in the inflammatory cytokine response after brain death after a minimum of 6 hours therapy with the GICT prior to organ procurement.

  • Assess organ (heart, liver, pancreas and kidney) survival at one year post-transplant

  • Assess graft function by evaluating:

  • Liver: post-transplant liver function score (PTLF)

  • Kidney: graft function as defined by UNOS (immediate graft function IGF, slow graft function SGF and delayed graft function DGF and

  • Pancreas: 7 day post-transplant insulin requirement, C-peptide and C-RP levels at day one and seven post-transplantation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Donors must be over 18 years of age
  • Brain death donors only
  • Getting consent prior to any specific protocol procedure under Transplant Quebec regulations.

排除标准

  • Inability to obtain a research consent
  • Time interval between the start of the study and cross-clamping less than 6 hours.
  • No solid organs retrieved for transplantation
  • Diagnosed with Type 1 Diabetes
  • Donor has uncontrolled serum blood glucose levels (above 10 mmol/L) at time of inclusion

结局指标

主要结局

• Drop in the inflammatory cytokine response after brain death after a minimum of 6 hours therapy with the GICT prior to organ procurement.

时间窗: during transplant

Our objective in this study will be to determine if implementing the glucose/insulin clamp (GICT) on cadaveric organ donors can: * Prevent hyperglycaemia * Drop in the inflammatory cytokine response after brain death after a minimum of 6 hours therapy with the GICT prior to organ procurement.

次要结局

  • Assess organ (heart, liver, pancreas and kidney) survival at one year post-transplant(1 year post-transplant)

研究者

发起方
McGill University Health Centre/Research Institute of the McGill University Health Centre
申办方类型
Other
责任方
Principal Investigator
主要研究者

peter metrakos

Director Multiorgan Transplant Program-MUHC

McGill University Health Centre/Research Institute of the McGill University Health Centre

研究点 (2)

Loading locations...

相似试验